Drug that targets immune cells shows potential as new treatment for diabetic heart disease

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage—not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart from within.